4
Changes in Ownership
Annexon, Inc. Filed Acc 0000899243-20-020805
10% owner bought 200,000 shares at $17.00 ($3,400,000)
- 10% owner acquired 2,530,635 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Clarus Lifesciences III, L.P. 10% owner | 2020-07-28 | Conversion | +643,208 | 643,208 | I | ||
| Clarus Lifesciences III, L.P. 10% owner | 2020-07-28 | Conversion | +950,134 | 1,593,342 | I | ||
| Clarus Lifesciences III, L.P. 10% owner | 2020-07-28 | Conversion | +697,860 | 2,291,202 | I | ||
| Clarus Lifesciences III, L.P. 10% owner | 2020-07-28 | Conversion | +239,433 | 2,530,635 | I | ||
| Clarus Lifesciences III, L.P. 10% owner | 2020-07-28 | Purchase | +200,000 | $17.00 | $3,400,000 | 2,730,635 | I |
| Derivatives | |||||||
| Clarus Lifesciences III, L.P. 10% owner | 2020-07-28 | Conversion · Series A-1 Redeemable Convertible Preferred Stock | −5,666,667 | 0 | I | ||
| Clarus Lifesciences III, L.P. 10% owner | 2020-07-28 | Conversion · Series B Redeemable Convertible Preferred Stock | −8,370,685 | 0 | I | ||
| Clarus Lifesciences III, L.P. 10% owner | 2020-07-28 | Conversion · Series C Redeemable Convertible Preferred Stock | −6,148,147 | 0 | I | ||
| Clarus Lifesciences III, L.P. 10% owner | 2020-07-28 | Conversion · Series D Redeemable Convertible Preferred Stock | −2,109,407 | 0 | I | ||
| Open-market purchases · 200,000 sh · avg $17.00 · $3,400,000 | |||||||
Loading xslF345X03/doc4.xml…